scholarly journals In vitro production by whole blood of pro- and anti-inflammatory cytokines in neonates with transposition of the great arteries having undergone arterial switch operation

Critical Care ◽  
10.1186/cc172 ◽  
1998 ◽  
Vol 2 (Suppl 1) ◽  
pp. P042
Author(s):  
MC Seghaye ◽  
K Schumacher ◽  
RG Grabitz ◽  
S Busse ◽  
S Däbritz ◽  
...  
1997 ◽  
Vol 41 (7) ◽  
pp. 1439-1443 ◽  
Author(s):  
J T Frieling ◽  
J A Mulder ◽  
T Hendriks ◽  
J H Curfs ◽  
C J van der Linden ◽  
...  

The in vitro production of interleukin-1beta (IL-1beta), IL-6, and the IL-1 receptor antagonist (IL-1ra) in whole blood upon stimulation with different bacterial strains was measured to study the possible relationship between disease severity and the cytokine-inducing capacities of these strains. Escherichia coli, Neisseria meningitidis, Neisseria gonorrhoeae, Bacteroides fragilis, Capnocytophaga canimorsus, Staphylococcus aureus, Enterococcus faecalis, Streptococcus pneumoniae, and Streptococcus pyogenes induced the cytokines IL-1beta, IL-6, and IL-1ra. Gram-negative bacteria induced significantly higher levels of proinflammatory cytokine production than gram-positive bacteria. These differences were less pronounced for the anti-inflammatory cytokine IL-1ra. In addition, blood was stimulated with E. coli killed by different antibiotics to study the effect of the antibiotics on the cytokine-inducing capacity of the bacterial culture. E. coli treated with cefuroxime and gentamicin induced higher levels of IL-1beta and IL-6 production but levels of IL-1ra production similar to that of heat-killed E. coli. In contrast, ciprofloxacin- and imipenem-cilastatin-mediated killing showed a decreased or similar level of induction of cytokine production as compared to that by heat-killed E. coli; polymyxin B decreased the level of production of the cytokines.


Reumatismo ◽  
2015 ◽  
Vol 66 (4) ◽  
pp. 277 ◽  
Author(s):  
P. Galozzi ◽  
O. Negm ◽  
E. Greco ◽  
N. Alkhattabi ◽  
A. Gava ◽  
...  

2019 ◽  
Vol 51 (2) ◽  
pp. 120-125
Author(s):  
M. Zagheh ◽  
R. Golmohammadi ◽  
M. Alahgholi-Hajibehzad ◽  
R. Najafi-Vosough ◽  
Z. Zareighane ◽  
...  

Cytokine ◽  
2012 ◽  
Vol 60 (1) ◽  
pp. 30-33 ◽  
Author(s):  
Marco Aurélio Echart Montano ◽  
Ivana Beatrice Mânica da Cruz ◽  
Marta Maria Medeiros Frescura Duarte ◽  
Cristina da Costa Krewer ◽  
Maria Izabel de Ugalde Marques da Rocha ◽  
...  

Critical Care ◽  
10.1186/cc176 ◽  
1998 ◽  
Vol 2 (Suppl 1) ◽  
pp. P046
Author(s):  
MC Seghaye ◽  
RG Grabitz ◽  
HH Hövels-Gürich ◽  
J Duchateau ◽  
S Däbritz ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Antonio Riva ◽  
Elena Palma ◽  
Dhruti Devshi ◽  
Douglas Corrigall ◽  
Huyen Adams ◽  
...  

Background and AimsImmunoregulatory checkpoint receptors (CR) contribute to the profound immunoparesis observed in alcohol-related liver disease (ALD) and in vitro neutralization of inhibitory-CRs TIM3/PD1 on anti-bacterial T-cells can rescue innate and adaptive anti-bacterial immunity. Recently described soluble-CR forms can modulate immunity in inflammatory conditions, but the contributions of soluble-TIM3 and soluble-PD1 and other soluble-CRs to immune derangements in ALD remain unclear.MethodsIn Alcoholic Hepatitis (AH; n = 19), alcohol-related cirrhosis (ARC; n = 53) and healthy control (HC; n = 27) subjects, we measured by Luminex technology (i) plasma levels of 16 soluble-CRs, 12 pro/anti-inflammatory cytokines and markers of gut bacterial translocation; (ii) pre-hepatic, post-hepatic and non-hepatic soluble-CR plasma levels in ARC patients undergoing TIPS; (iii) soluble-CRs production from ethanol-treated immunocompetent precision cut human liver slices (PCLS); (iv) whole-blood soluble-CR expression upon bacterial challenge. By FACS, we assessed the relationship between soluble-TIM3 and membrane-TIM3 and rescue of immunity in bacterial-challenged PBMCs.ResultsSoluble-TIM3 was the dominant plasma soluble-CR in ALD vs. HC (p = 0.00002) and multivariate analysis identified it as the main driver of differences between groups. Soluble-CRs were strongly correlated with pro-inflammatory cytokines, gut bacterial translocation markers and clinical indices of disease severity. Ethanol exposure or bacterial challenge did not induce soluble-TIM3 production from PCLS nor from whole-blood. Bacterial challenge prompted membrane-TIM3 hyperexpression on PBMCs from ALD patient’s vs. HC (p < 0.002) and was inversely correlated with plasma soluble-TIM3 levels in matched patients. TIM3 ligands soluble-Galectin-9 and soluble-CEACAM1 were elevated in ALD plasma (AH > ARC; p < 0.002). In vitro neutralization of Galectin-9 and soluble-CEACAM1 improved the defective anti-bacterial and anti-inflammatory cytokine production from E. coli-challenged PBMCs in ALD patients.ConclusionsAlcohol-related liver disease patients exhibit supra-physiological plasma levels of soluble-TIM3, particularly those with greater disease severity. This is also associated with increased levels of soluble TIM3-ligands and membrane-TIM3 expression on immune cells. Soluble-TIM3 can block the TIM3-ligand synapse and improve anti-bacterial immunity; however, the increased levels of soluble TIM3-binding ligands in patients with ALD negate any potential immunostimulatory effects. We believe that anti-TIM3 neutralizing antibodies currently in Phase I clinical trials or soluble-TIM3 should be investigated further for their ability to enhance anti-bacterial immunity. These agents could potentially represent an innovative immune-based supportive approach to rescue anti-bacterial defenses in ALD patients.


Sign in / Sign up

Export Citation Format

Share Document